Suppr超能文献

结直肠癌治疗后5年性功能不佳的患病率及预测因素:结直肠癌健康状况(CREW)前瞻性纵向研究结果

Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study.

作者信息

Frankland Jane, Wheelwright Sally, Permyakova Natalia V, Wright David, Collaço Nicole, Calman Lynn, Winter Jane, Fenlon Deborah, Richardson Alison, Smith Peter W, Foster Claire

机构信息

Macmillan Survivorship Research Group, School of Health Sciences, University of Southampton, Southampton, UK.

University Hospital Southampton NHS Foundation Trust, Southampton, UK.

出版信息

BMJ Open. 2020 Nov 12;10(11):e038953. doi: 10.1136/bmjopen-2020-038953.

Abstract

OBJECTIVES

To describe prevalence and predictors of poor sexual well-being for men and women over 5 years following treatment for colorectal cancer.

DESIGN

Prospective longitudinal study, from presurgery to 5 years postsurgery, with eight assessment points. Logistic regression models predicted sexual well-being from presurgery to 24 months and 24 months to 60 months; time-adjusted then fully adjusted models were constructed at each stage.

SETTING

Twenty-nine hospitals in the UK.

PARTICIPANTS

Patients with Dukes' stage A-C, treated with curative intent, aged ≥18 years and able to complete questionnaires were eligible.

OUTCOME MEASURES

The dependent variable was the Quality of Life in Adult Cancer Survivors sexual function score. Independent variables included sociodemographic, clinical and psychosocial characteristics.

RESULTS

Seven hundred and ninety participants provided a sexual well-being score for at least one time point. Thirty-seven per cent of men and 14% of women reported poor sexual well-being at 5 years. Baseline predictors for men at 24 months included having a stoma (OR 1.5, 95% CI 1.02 to 2.20) and high levels of depression (OR 2.69/2.01, 95% CI 1.68 to 4.32/1.12 to 3.61); men with high self-efficacy (OR confident 0.33/0.48, 95% CI 0.18 to 0.61/0.24 to 1.00; very confident 0.25/0.42, 95% CI 0.13 to 0.49/0.19 to 0.94) and social support (OR 0.52/0.56, 95% CI 0.33 to 0.81/0.35 to 0.91) were less likely to report poor sexual well-being. Predictors at 60 months included having a stoma (OR 2.30/2.67, 95% CI 1.22 to 4.34/1.11 to 6.40) and high levels of depression (OR 5.61/2.58, 95% CI 2.58 to 12.21/0.81 to 8.25); men with high self-efficacy (very confident 0.14, 95% CI 0.047 to 0.44), full social support (OR 0.26; 95% CI 0.13 to 0.53) and higher quality of life (OR 0.97, 95% CI 0.95 to 0.98) were less likely to report poor sexual well-being. It was not possible to construct models for women due to low numbers reporting poor sexual well-being.

CONCLUSIONS

Several psychosocial variables were identified as predictors of poor sexual well-being among men. Interventions targeting low self-efficacy may be helpful. More research is needed to understand women's sexual well-being.

摘要

目的

描述结直肠癌治疗后5年男性和女性性功能不良的患病率及预测因素。

设计

前瞻性纵向研究,从术前到术后5年,共8个评估点。逻辑回归模型预测术前至术后24个月以及术后24个月至60个月的性功能状况;在每个阶段构建时间调整模型,然后进行完全调整模型。

地点

英国29家医院。

参与者

符合条件的患者为年龄≥18岁、接受根治性治疗、处于Dukes A - C期且能够完成问卷的患者。

观察指标

因变量为成年癌症幸存者性功能评分中的生活质量。自变量包括社会人口学、临床和心理社会特征。

结果

790名参与者至少在一个时间点提供了性功能评分。5年时,37%的男性和14%的女性报告性功能不良。术后24个月男性的基线预测因素包括造口(比值比1.5,95%置信区间1.02至2.20)和高抑郁水平(比值比2.69/2.01,95%置信区间1.68至4.32/1.12至3.61);自我效能感高的男性(自信:比值比0.33/0.48,95%置信区间0.18至0.61/0.24至1.00;非常自信:比值比0.25/0.42,95%置信区间0.13至0.49/0.19至0.94)和社会支持高的男性(比值比0.52/0.56,95%置信区间0.33至0.81/0.35至0.91)报告性功能不良的可能性较小。术后60个月的预测因素包括造口(比值比2.30/2.67,95%置信区间1.22至4.34/1.11至6.40)和高抑郁水平(比值比5.61/2.58,95%置信区间2.58至12.21/0.81至8.25);自我效能感高(非常自信:比值比0.14,95%置信区间0.047至0.44)、完全社会支持(比值比0.26;95%置信区间0.13至0.53)和生活质量较高(比值比0.97,95%置信区间0.95至0.98)的男性报告性功能不良的可能性较小。由于报告性功能不良的女性数量较少,无法为女性构建模型。

结论

确定了几个心理社会变量为男性性功能不良的预测因素。针对低自我效能感的干预可能会有帮助。需要更多研究来了解女性的性功能状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c99/7662451/8686851e88f9/bmjopen-2020-038953f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验